Dennis H. Langer, M.D., J.D. 

Dr. Langer is currently Managing Partner of Phoenix IP Ventures, LLC, a venture capital firm in Philadelphia. Prior to joining Phoenix IPV, he was most recently President, North America, Dr. Reddy's Laboratories, an emerging global pharmaceutical company. Previously, Dr. Langer was with GlaxoSmithKline (GSK) for nine years. His last position with GSK was as a member of the R&D Executive Team and as Senior Vice President, Project and Portfolio Management. In addition, he was also responsible for Alliance Management. Prior to the merger of Glaxo Wellcome and SmithKline Beecham, Dr. Langer was Senior Vice President of Product Development Strategy and Senior Vice President of Research and Development, Healthcare Services with SmithKline Beecham. He also held senior management positions with major pharmaceutical companies such as Searle, Abbott and Eli Lilly. Dr. Langer also served as the first President and Chief Executive Officer of Neose Technologies, Inc.

Dr. Langer earned an M.D. from Georgetown University School of Medicine, a J.D. (cum laude) from Harvard Law School, and a B.A. in Biology from Columbia University. Dr. Langer was Chief Resident in psychiatry at Yale University School of Medicine and held clinical fellowships in psychiatry at the National Institutes of Health, Harvard Medical School, and George Washington University School of Medicine. Dr. Langer currently serves on the Boards of Myriad Genetics, Inc. and Cytogen Corporation. Until recently, Dr. Langer also served on the Board of Sirna Therapeutics, Inc. He also serves on the Boards of Visitors at Columbia College, Columbia University and Georgetown University School of Medicine. He is a Clinical Professor, Department of Psychiatry, Georgetown University School of Medicine.